These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38100041)

  • 21. FL118, a novel camptothecin analogue, overcomes irinotecan and topotecan resistance in human tumor xenograft models.
    Ling X; Liu X; Zhong K; Smith N; Prey J; Li F
    Am J Transl Res; 2015; 7(10):1765-81. PubMed ID: 26692923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening.
    Fan G; Luo X; Shi Y; Wang Y; Ji L; Gong Y; Yang E; Chen C; Cui S; Ding H; Zhang Z; Wang J; Liu Y; Wang Z
    Bioorg Chem; 2024 Dec; 153():107802. PubMed ID: 39244972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kras mutation subtypes distinctly affect colorectal cancer cell sensitivity to FL118, a novel inhibitor of survivin, Mcl-1, XIAP, cIAP2 and MdmX.
    Thangaiyan R; Aljahdali IA; Lent-Moore KY; Liao J; Ling X; Li F
    Am J Transl Res; 2021; 13(7):7458-7474. PubMed ID: 34377229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An intravenous (i.v.) route-compatible formulation of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, improves FL118 antitumor efficacy and therapeutic index (TI).
    Ling X; Li F
    Am J Transl Res; 2013; 5(2):139-54. PubMed ID: 23573360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer drug FL118 is more than a survivin inhibitor: where is the Achilles' heel of cancer?
    Li F
    Am J Cancer Res; 2014; 4(3):304-11. PubMed ID: 24959385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
    Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
    Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FL118, a novel survivin inhibitor, wins the battle against drug-resistant and metastatic lung cancers through inhibition of cancer stem cell-like properties.
    Wang J; Liu Z; Zhang D; Liu R; Lin Q; Liu J; Yang Z; Ma Q; Sun D; Zhou X; Jiang G
    Am J Transl Res; 2017; 9(8):3676-3686. PubMed ID: 28861158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of survivin inhibitors and beyond: FL118 as a proof of concept.
    Li F
    Int Rev Cell Mol Biol; 2013; 305():217-52. PubMed ID: 23890383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
    J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric synthesis of phenanthroindolizidine alkaloids with hydroxyl group at the C14 position and evaluation of their antitumor activities.
    Ikeda T; Yaegashi T; Matsuzaki T; Hashimoto S; Sawada S
    Bioorg Med Chem Lett; 2011 Jan; 21(1):342-5. PubMed ID: 21126872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antitumor activity of novel substituted uracil-1'(N)-acetic acid ester derivatives of 20(S)-camptothecins.
    Li DZ; Zhang QZ; Wang CY; Zhang YL; Li XY; Huang JT; Liu HY; Fu ZD; Song HX; Lin JP; Ji TF; Pan XD
    Eur J Med Chem; 2017 Jan; 125():1235-1246. PubMed ID: 27871039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
    Santha S; Ling X; Aljahdali IAM; Rasam SS; Wang X; Liao J; Wang J; Fountzilas C; Li Q; Qu J; Li F
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33217967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 7-substituted camptothecins with potent antitumor activity.
    Dallavalle S; Delsoldato T; Ferrari A; Merlini L; Penco S; Carenini N; Perego P; De Cesare M; Pratesi G; Zunino F
    J Med Chem; 2000 Oct; 43(21):3963-9. PubMed ID: 11052801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake and efflux of FL118 and two FL118 derivatives in 3D cell model.
    Zhou L; Weng Q; Zheng Y; Zhou Y; Li Q; Li F
    Cytotechnology; 2019 Jul; 71(4):785-795. PubMed ID: 31309350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 3- and 29-substituted celastrol derivatives and structure-activity relationship studies of their cytotoxic activities.
    Shan WG; Wang HG; Chen Y; Wu R; Wen YT; Zhang LW; Ying YM; Wang JW; Zhan ZJ
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3450-3453. PubMed ID: 28587825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine.
    Rivera M; Fichtner I; Wulf-Goldenberg A; Sers C; Merk J; Patone G; Alp KM; Kanashova T; Mertins P; Hoffmann J; Stein U; Walther W
    Neoplasia; 2021 Jan; 23(1):21-35. PubMed ID: 33212364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor Activity.
    Lu B; Liu D; Gui B; Gou J; Dong H; Hu Q; Feng J; Mao Y; Shen X; Wang S; Zhang C; Shen R; Yan Y; Chen L; Wang H; Li D; Zhang J; Zhang M; Zhang R; Bai C; He F; Tao W; Liu S
    J Med Chem; 2021 Oct; 64(20):14983-14996. PubMed ID: 34643383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy.
    Zhang Y; Yin R; Wu G; Yu M; Liu J; Wang X; Liu X; Guan H; Yu R; Jiang T
    Eur J Med Chem; 2020 Aug; 200():112365. PubMed ID: 32460113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of new 7-(N-substituted-methyl)-camptothecin derivatives as potent cytotoxic agents.
    Zhao XB; Goto M; Song ZL; Morris-Natschke SL; Zhao Y; Wu D; Yang L; Li SG; Liu YQ; Zhu GX; Wu XB; Lee KH
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3850-3. PubMed ID: 25008456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models.
    Reipsch F; Biersack B; Lucas H; Schobert R; Mueller T
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.